Received Mar 15, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMR | MEASLES + MUMPS + RUBELLA (MMR II) | MERCK & CO. INC. | UNK | — | — |
| MMR | MEASLES + MUMPS + RUBELLA (MMR II) | MERCK & CO. INC. | UNK | — | — |
| VARCEL | VARICELLA (VARIVAX) | MERCK & CO. INC. | UNK | — | — |
| VARCEL | VARICELLA (VARIVAX) | MERCK & CO. INC. | UNK | — | — |
Customer called asking about the need for re-vaccination for MMR and VARIVAX. Customer said she was re-vaccinated for VARIVAX in 2020 or 2021 for a job. She had a "blood test" recently and it shows that she "does not have immunity" for either VARIVAX; This spontaneous report was received from a consumer referring to herself, a female patient of unknown age. The patient's pertinent medical history, concurrent conditions, previous drug reactions or allergies and concomitant medications were not reported. On an unknown date (reported as in 2020 or 2021), the patient was re-vaccinated for a job, with Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II) and with Varicella Virus Vaccine Live (Oka-Merck) (VARIVAX), (doses, routes of administration, anatomical sites of injection, lot numbers and expiration dates were not reported); both vaccines administered for prophylaxis. On unknown date (reported as recently), the patient took a blood test and it showed that she didn't have immunity for either Varicella Virus Vaccine Live (Oka-Merck) (VARIVAX) or Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II) (Antibody test negative). At the time of the reporting, the outcome of the event was unknown. The causal relationship between the event and the suspect therapies was not provided.